REQUEST A DEMO
Total
USD $0.00
Search more companies

New Ray Medicine International Holding Limited (Hong Kong SAR, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: New Ray Medicine International Holding Limited Profile Updated: October 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

New Ray Medicine International Holding Limited is an established pharmaceutical distributor originated from Zhejiang province and headquartered in Hangzhou, Zhejiang province. It is principally engaged in pharmaceutical distribution businesses in the PRC with a focus in Zhejiang province. It mainly serve as a provincial pharmaceutical distributor, and also a national distributor for some of our products. They start involving their pharmaceutical distribution business from the stage of acquisition of distribution rights of pharmaceutical products from its suppliers, conducting market research and market development of its new products, assistance and co-ordination in the collective tendering process for its suppliers, procurement, sourcing, sales and marketing, warehousing and delivery to its Distributor Customers.

Headquarters
Room 911B, 9Th Floor, Tower 1, Silvercord
Hong Kong; Hong Kong;

Contact Details: Purchase the New Ray Medicine International Holding Limited report to view the information.

Website: http://www.newraymedicine.com

Basic Information
Total Employees:
Purchase the New Ray Medicine International Holding Limited report to view the information.
Outstanding Shares:
Purchase the New Ray Medicine International Holding Limited report to view the information.
Registered Capital:
Purchase the New Ray Medicine International Holding Limited report to view the information.
Financial Auditors:
Purchase the New Ray Medicine International Holding Limited report to view the information.
Incorporation Date:
2012
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
25.52%
Purchase this report to view the information.
11.59%
Purchase this report to view the information.
9.65%
Purchase this report to view the information.
9.65%
Purchase this report to view the information.
Subsidiaries
Max Goodrich International Limited (United Kingdom)
100%
Major Bright Holdings Limited (United Kingdom)
Company Performance
Financial values in the chart are available after New Ray Medicine International Holding Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HKD. Absolute financial data is included in the purchased report.
Net sales revenue
-77.11%
Total operating revenue
-77.05%
Operating profit (EBIT)
30.15%
EBITDA
9.73%
Net Profit (Loss) for the Period
69.39%
Total assets
-6.07%
Total equity
-5.2%
Operating Profit Margin (ROS)
-17.43%
Net Profit Margin
-6.16%
Return on Equity (ROE)
1.83%
Debt to Equity Ratio
-0.02%
Quick Ratio
2.32%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?